More recently, CRP/albumin ratios have been proven to be a powerful mortality prognosis marker in hypertensive COVID-19 adults (40), and systematic research should be performed in order to assess the screening and diagnostic accuracy of this serologic marker. The gene discussed is CRP; the disease is COVID-19.